Hospitals Charge Average 500% of Top 20 Drug Costs, Says PhRMA-Funded Analysis

The Moran Company logo
A Moran Company study, funded by PhRMA, found 340B hospitals charge an average of 500% above acquisition costs for 20 high-cost drugs.
Hospitals charge, on average, 500% of their acquisition cost for 20 individual medicines that account for the largest share of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Claims Clearinghouse, Strengthening HRSA Among Few Consensus Areas in Responses to Senate 340B Overhaul Effort

Sen. John Thune
Sen. John Thune is part of a bipartisan group of six senators that solicited stakeholder advice on strategies to reform the 340B program.
The creation of a claims clearinghouse and increasing both the funding and authority of the federal agency overseeing the 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Do 340B Lump Sum Payments Underscore Need for More Transparency or Are They Unrelated?

Peter Pitts
Peter Pitts, president of the Center for Medicine in the Public Interest, says the recently released 340B Medicare lump sum payments underscore the need for more 340B program transparency.
A recently proposed list of planned Medicare payments for individual 340B hospitals is seen as ammunition to some 340B critics. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Amid Historic Financial Challenges, 340B Proposed Payments Will ‘Make a Difference’ for Some Hospitals’ Budgets, Says Rating Official

Fitch Ratings webinar
A Fitch Ratings webinar on the not-for-profit hospital sector discussed the financial implications of the proposed $9 billion lump sum Medicare payment to make up for five years of illegal 340B cuts.
As the not-for-profit hospital sector slowly emerges from its worst financial year in recent history, some of those organizations’ bottom [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Panel Passes PBM Reform Bill With Medicaid Drug Payment Limits and 340B Reporting Requirements

Senate Finance Committee PBM reform bill markup.
The Senate Finance Committee voted 26-1 to pass a PBM reform bill with Medicaid spread pricing language that could result in less 340B savings for covered entities.
The U.S. Senate Finance Committee yesterday voted 26-1 to pass a pharmacy benefit manager reform bill that would cut providers’ [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

100+ Health Centers and Groups Sign Pro-340C Letter to Congress

340C
More than 100 health centers and groups have signed a letter to Congress supporting the 340C initiative.
More than 100 community health centers, state primary care associations, and national and local groups urged congressional leaders this week [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Sends Previously Audited 340B Hospital a Second Follow-up Compliance Letter

HRSA headquarters
The Health Resources and Services Administration announced that the Office of Pharmacy Affairs will hold a June 11 webinar on the ADR final rule.
A hospital that the U.S. Health Resources and Services Administration audited for 340B program compliance and then was one of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CMS’s 340B Hospital Repayment Plan Leaves Medicare Advantage Cuts Untouched

Attorney Kyle Vasquez
Attorney Kyle Vasquez says many clients feel they are entitled to a remedy for underpayments from Medicare Advantage plans stemming from CMS' July 7 proposed rule.
The recently proposed Medicare fee-for-service lump sum payments to 340B hospitals to make up for a nearly five-year unlawful rate [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Recertification for Hospitals Starts Aug. 14

HRSA hospital recertification.
HRSA announced this year's 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11.
This year’s 340B eligibility recertification period for hospitals will start Aug. 14 and end Sept. 11, the U.S. Health Resources [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Large Drug Maker, Big Health System, and Influential Health Center Jointly Lobbying for Senate Bipartisan 340B Initiative

340B Working Table 340B lobbying disclosure form
Under the name 340B Working Table, Genentech, Sanford Health, and Carolina Health Centers are jointly lobbying for a bipartisan U.S. Senate 340B reform initiative.

Biopharmaceutical manufacturer Genentech, South Dakota-based health system Sanford Health, and South Carolina federally qualified health center Carolina Health Centers are jointly lobbying members of Congress to back six U.S. senators’ bipartisan approach to federal 340B program reform, the three organizations

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live